Study suggests inhaled technosphere insulin could be considered as an option for adults with type 1 diabetes

A study in the journal Diabetes Technology & Therapeutics (DTT) concludes that inhaled technosphere insulin (TI-Afrezza) should be considered as an option for individuals with type 1 diabetes who want an alternative to using an insulin pump or multiple daily injections (MDI) for insulin delivery.
đ Full Story

Woman SPITS on Black Woman for SITTING to CLOSE to Her Husband at Elementary School Graduation!
- Spotify's latest custom playlist highlights artists with upcoming shows in your area - Kris Holt
- Killer Claustrophobic Creature Feature On Tubi Tears You To Shreds - Chris Snellgrove
- The Ultimate Guide to AI Call Centers - seo
- Kanye Westâs ex-partner Amber Rose explains real reason he âdresses girlfriends in X-rated outfitsâ (Video) - Isaiah Amos
- NCI employees canât publish information on these topics without special approval - Annie Waldman and Lisa Song, ProPublica
- Surgery for Ingrown Toenails: Procedure, Recovery, and Prevention - Carrie Madormo, RN, MPH

Is This The Most Powerful Smartphone at 24,999? ft. iQOO Neo 10R
- Risky Chemicals Are Lurking in Perfumes and ColognesâHere's How to Reduce Your Exposure - Kaitlin Sullivan
- âNever Seen Anything Like Thisâ: Crucial Voter Groups Fleeing Democrats, Says Stunned Fmr Clinton Pollster - Mariane Angela
- Ultrafine bubble showers may help suppress atopic dermatitis
- Roblox wants to improve discovery for its game creators - Dean Takahashi
- Beyond RAG: SEARCH-R1 integrates search engines directly into reasoning models - Ben Dickson
- Kate Garraway interrupts ITVâs Good Morning Britain for urgent breaking news announcement - Isaiah Amos